TY - JOUR
T1 - An international comparison of HIV prevalence and incidence in blood donors and general population
T2 - a BEST Collaborative study
AU - for the BEST Collaborative
AU - Germain, Marc
AU - Grégoire, Yves
AU - Custer, Brian S.
AU - Goldman, Mindy
AU - Bravo, Marjorie
AU - Kamel, Hany
AU - Davison, Katy
AU - Field, Stephen
AU - van den Hurk, Katja
AU - van de Laar, Thijs J.W.
AU - Irving, David O.
AU - Jones, Ann
AU - Liumbruno, Giancarlo
AU - Morley, Sarah
AU - O’Brien, Sheila F.
AU - Pillonel, Josiane
AU - Steinsvåg, Christine Torsvik
AU - Takanashi, Minoko
AU - Tsuno, Nelson Hirokazu
AU - Vesga Carasa, Miguel Angel
AU - Wendel, Silvano
AU - Vassallo, Ralph R.
AU - Tiberghien, Pierre
N1 - Publisher Copyright:
© 2021 International Society of Blood Transfusion
PY - 2021/11
Y1 - 2021/11
N2 - Background and Objectives Efficiency in mitigating HIV transmission risk by transfusion may vary internationally. We compared HIV prevalence and incidence in blood donors across different jurisdictions in relation to those rates in the general population and differences in deferral practices.Materials and Methods Data from 2007 to 2016 were collected in Australia, Brazil (Sao Paulo), Canada, England, France, Italy, Ireland, Japan, the Netherlands, New Zealand, Norway, Spain (Basque Country), USA (Vitalant) and Wales. For each country/region, the number of HIV antibody-positive donations and nucleic acid testing (NAT)-only-positive donations was broken down according to first-time or repeat donor status, along with the relevant denominators.Results There is a modest correlation between HIV prevalence among first-time donors and HIV prevalence in the general population. However, rates of HIV-positive donations in repeat donors, a proxy for incidence, do not correlate with incidence rates in the general population. Rates in donors from Italy and Basque Country, where deferral criteria for men having sex with men are less stringent, are higher compared with most other jurisdictions. Rates of NAT-only-positive donations are extremely low and do not differ significantly after adjustment for multiple comparisons.Conclusion Donor HIV rates are only weakly associated with those observed in the general population. Countries with less stringent deferral criteria have higher HIV rates in their donor population, but the rates remain very low.
AB - Background and Objectives Efficiency in mitigating HIV transmission risk by transfusion may vary internationally. We compared HIV prevalence and incidence in blood donors across different jurisdictions in relation to those rates in the general population and differences in deferral practices.Materials and Methods Data from 2007 to 2016 were collected in Australia, Brazil (Sao Paulo), Canada, England, France, Italy, Ireland, Japan, the Netherlands, New Zealand, Norway, Spain (Basque Country), USA (Vitalant) and Wales. For each country/region, the number of HIV antibody-positive donations and nucleic acid testing (NAT)-only-positive donations was broken down according to first-time or repeat donor status, along with the relevant denominators.Results There is a modest correlation between HIV prevalence among first-time donors and HIV prevalence in the general population. However, rates of HIV-positive donations in repeat donors, a proxy for incidence, do not correlate with incidence rates in the general population. Rates in donors from Italy and Basque Country, where deferral criteria for men having sex with men are less stringent, are higher compared with most other jurisdictions. Rates of NAT-only-positive donations are extremely low and do not differ significantly after adjustment for multiple comparisons.Conclusion Donor HIV rates are only weakly associated with those observed in the general population. Countries with less stringent deferral criteria have higher HIV rates in their donor population, but the rates remain very low.
KW - NAT testing
KW - blood donation testing
KW - blood safety
KW - donors
KW - epidemiology
KW - transfusion – transmissible infections
UR - http://www.scopus.com/inward/record.url?scp=85104347814&partnerID=8YFLogxK
U2 - 10.1111/vox.13107
DO - 10.1111/vox.13107
M3 - Article
C2 - 33835513
AN - SCOPUS:85104347814
SN - 0042-9007
VL - 116
SP - 1084
EP - 1093
JO - Vox Sanguinis
JF - Vox Sanguinis
IS - 10
ER -